|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7,416.00 JPY | +2.83% |
|
+1.24% | -10.03% |
| 07-24 | Chugai Pharmaceutical Co., Ltd., Q2 2026 Earnings Call, Jul 24, 2026 | |
| 07-24 | Chugai Pharmaceutical's H1 Profit Jumps 19% | MT |
| Market Cap | 12,202B 74.54B 65.47B 60.88B 55.87B 105B 7,178B 107B 723B 282B 3,529B 280B 274B | P/E 2026 * |
24.1x | P/E 2027 * | 20.6x |
|---|---|---|---|---|---|
| Enterprise Value | 11,174B 68.26B 59.95B 55.75B 51.16B 96.13B 6,574B 97.61B 662B 259B 3,232B 256B 251B | EV / Sales 2026 * |
8.05x | EV / Sales 2027 * | 7.18x |
| Free-Float |
38.12% | Yield 2026 * |
1.84% | Yield 2027 * | 2.12% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +2.83% | ||
| 1 week | +1.24% | ||
| Current month | -1.57% | ||
| 1 month | -1.12% | ||
| 3 months | -16.16% | ||
| 6 months | -15.27% | ||
| Current year | -10.03% |
| 1 week | 7,163 |  | 7,509 |
| 1 month | 7,105 | | 7,939 |
| Current year | 7,105 | | 10,700 |
| 1 year | 5,942 | | 10,700 |
| 3 years | 3,990 | | 10,700 |
| 5 years | 3,191 | | 10,700 |
| 10 years | 1,003.33 | | 10,700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 63 | 01/03/2021 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | 59 | 28/03/2024 |
Kazuhiko Nishi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
BRD | Director/Board Member | 63 | 01/03/2020 |
Iwaaki Taniguchi
BRD | Director/Board Member | 59 | 28/03/2024 |
| Director/Board Member | 51 | 01/03/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.83% | +1.24% | +2.46% | +82.26% | 74.54B | |
| +0.86% | +1.43% | +48.50% | +160.39% | 1,067B | |
| +1.59% | +4.09% | +55.34% | +53.96% | 635B | |
| +0.95% | +1.91% | +35.91% | +81.14% | 458B | |
| +1.60% | +6.25% | +33.95% | +29.84% | 347B | |
| -0.60% | +1.52% | +35.68% | +39.76% | 295B | |
| -0.14% | +0.60% | +16.17% | +17.53% | 262B | |
| +0.09% | -2.82% | -28.29% | -41.71% | 216B | |
| +1.22% | +2.66% | +21.87% | +59.73% | 203B | |
| -1.18% | -3.70% | +14.23% | +66.51% | 161B | |
| Average | +0.62% | +1.32% | +23.58% | +54.94% | 371.75B | |
| Weighted average by Cap. | +0.59% | +1.94% | +35.14% | +77.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1,388B 8.48B 7.45B 6.93B 6.36B 11.95B 817B 12.13B 82.27B 32.14B 402B 31.84B 31.15B | 1,538B 9.39B 8.25B 7.67B 7.04B 13.23B 905B 13.43B 91.11B 35.59B 445B 35.26B 34.5B |
| Net income | 507B 3.1B 2.72B 2.53B 2.32B 4.36B 298B 4.43B 30.04B 11.74B 147B 11.63B 11.38B | 592B 3.62B 3.18B 2.95B 2.71B 5.09B 348B 5.17B 35.09B 13.71B 171B 13.58B 13.29B |
| Net Debt | -1,028B -6.28B -5.51B -5.13B -4.71B -8.84B -605B -8.98B -60.89B -23.79B -297B -23.57B -23.06B | -1,164B -7.11B -6.24B -5.81B -5.33B -10.01B -685B -10.17B -68.95B -26.94B -337B -26.69B -26.11B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/07/26 | ¥7,416.00 | +2.83% | 2,827,400 |
| 23/07/26 | ¥7,212.00 | -1.29% | 2,609,800 |
| 22/07/26 | ¥7,306.00 | -1.23% | 2,064,700 |
| 21/07/26 | ¥7,397.00 | +0.98% | 3,264,000 |
| 17/07/26 | ¥7,325.00 | +1.16% | 2,964,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
